• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[关于止血与血栓形成领域术语和方法标准化的国际努力]

[An international attempt for standardization on terminology and methodology in hemostasis and thrombosis].

作者信息

Tsukada T

机构信息

Division of Hematologic Research, Toranomon Hospital.

出版信息

Rinsho Ketsueki. 1994 May;35(5):469-74.

PMID:8028194
Abstract

Scientific and Standardization Committee (SSC) of International Thrombosis and Hemostasis has acted its activity since 1955 for establishing international concept on terminology, methodology in the fields of blood platelets, coagulation and fibrinolysis. Among the reports from 15 sub-committee in 1993 meeting, some clinically interesting topics are reported. In von Willebrand factor (vWF) Subcommittee, new classification of von Willebrand disease including new variant of VFW which shows defect on factor VIII binding capacity, is proposed. In Control of Anticoagulation Subcommittee, the necessity of coagulation monitoring during low molecular weight heparin (LMWH) administration was discussed. For prophylaxis use, monitoring is unnecessary except patients having renal failure or high-low body weight. For the treatment of venous thrombosis once or twice monitoring every 10 days would be necessary. In Lupus anticoagulant (LA)/phospholipid dependent antibodies Subcommittee, results of 3rd international survey for LA sent to 38 laboratories in 16 countries including Japan were reported. Most laboratory used APTT and dRVVT simultaneously as screening tests. Sensitivity and specificity of confirmatory test for LA are compared; the best one was Staclot LA and the second was DVVT.

摘要

国际血栓形成与止血科学标准化委员会(SSC)自1955年起开展活动,旨在确立血小板、凝血和纤维蛋白溶解领域术语及方法的国际概念。在1993年会议上15个小组委员会的报告中,有一些具有临床意义的主题被报道。在血管性血友病因子(vWF)小组委员会中,提出了血管性血友病的新分类,包括一种显示因子VIII结合能力缺陷的血管性血友病新变体。在抗凝控制小组委员会中,讨论了低分子量肝素(LMWH)给药期间凝血监测的必要性。对于预防性使用,除了肾衰竭或体重过高或过低的患者外,无需进行监测。对于静脉血栓形成的治疗,每10天进行一到两次监测是必要的。在狼疮抗凝物(LA)/磷脂依赖性抗体小组委员会中,报告了发送给包括日本在内的16个国家38个实验室的第三次LA国际调查结果。大多数实验室同时使用活化部分凝血活酶时间(APTT)和稀释的蝰蛇毒时间(dRVVT)作为筛查试验。比较了LA确证试验的敏感性和特异性;最佳的是Staclot LA,其次是稀释蝰蛇毒时间(DVVT)。

相似文献

1
[An international attempt for standardization on terminology and methodology in hemostasis and thrombosis].[关于止血与血栓形成领域术语和方法标准化的国际努力]
Rinsho Ketsueki. 1994 May;35(5):469-74.
2
von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.基于儿科人群的血管性血友病——1型诊断标准及血小板功能分析仪-100和血管性血友病因子/胶原结合试验应用的比较
Thromb Haemost. 2000 Sep;84(3):401-9.
3
Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.肝素治疗实验室监测的局限性。科学与标准化委员会通讯:代表国际血栓与止血学会科学与标准化委员会抗凝控制小组委员会。
Thromb Haemost. 2002 Jan;87(1):163-4.
4
Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.血管性血友病因子的凝血因子 VIII 结合试验与 2N 型血管性血友病的诊断——一项国际调查结果。代表国际血栓与止血学会科学与标准化委员会血管性血友病因子小组委员会。
Thromb Haemost. 1996 Aug;76(2):270-4.
5
A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.血管性血友病的修订分类。国际血栓与止血协会科学和标准化委员会血管性血友病因子小组委员会制定。
Thromb Haemost. 1994 Apr;71(4):520-5.
6
Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.胶原结合酶联免疫吸附测定法与瑞斯托霉素辅因子活性测定法检测血管性血友病因子功能活性的比较研究
Semin Thromb Hemost. 2002 Apr;28(2):149-60. doi: 10.1055/s-2002-27817.
7
Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.欧洲狼疮抗凝物检测:对首次欧洲血栓形成倾向协调行动(ECAT)调查结果的分析,该调查使用了添加抗人β2糖蛋白I单克隆抗体的血浆。
Thromb Haemost. 1999 Jun;81(6):929-34.
8
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.弥散性血管内凝血诊断与管理指南。英国血液学标准委员会。
Br J Haematol. 2009 Apr;145(1):24-33. doi: 10.1111/j.1365-2141.2009.07600.x. Epub 2009 Feb 12.
9
Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.狼疮抗凝物与血栓形成:不同凝血及免疫学检测的临床关联
Thromb Haemost. 2000 Dec;84(6):1012-6.
10
A perspective on the use of FVIII concentrates and cryoprecipitate prophylactically in surgery or therapeutically in severe bleeds in patients with von Willebrand disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.关于在对去氨加压素无反应的血管性血友病患者中预防性使用FVIII浓缩物和冷沉淀用于手术或治疗严重出血的观点:一项国际调查结果。代表国际血栓与止血学会科学和标准化委员会血管性血友病因子小组委员会。
Thromb Haemost. 1995 Nov;74(5):1370-8.